Skip to main content
. 2020 May 4;2(6):e358–e367. doi: 10.1016/S2665-9913(20)30096-5

Table 2.

Pharmacokinetic comparison of single dose intravenous and subcutaneous anakinra in healthy volunteers*

Intravenous (100 mg) Subcutaneous (100 mg)
Healthy volunteers 7 8
Cmax (ng/mL) 32 193 1326
Tmax (h) Not applicable 4·3
t1/2(h) 1·69 3·63
AUC (ng*hour/mL) 14 658 13 266
CL (mL/min) 122 134

Data are presented as mean values. Cmax= maximum plasma concentration. Tmax=time at which Cmax occurred. t1/2=terminal half-life. AUC=area under plasma concentration-time curve from time 0 to infinity. CL=plasma clearance.

*

Adapted from Yang and et al.56

These data represent volunteers with a body-mass index <35 and a body weight ≤90 kg.

HHS Vulnerability Disclosure